Canada to wait longer than Europe for Pfizer-BioNTech COVID-19 vaccine - The Globe and Mail | Canada News Media
Connect with us

Business

Canada to wait longer than Europe for Pfizer-BioNTech COVID-19 vaccine – The Globe and Mail

Published

 on


A truck enters the Pfizer manufacturing plant in Puurs, Belgium, on Dec. 21, 2020.

Valentin Bianchi/The Associated Press

The European Union will have a much shorter interruption in deliveries of the Pfizer-BioNTech COVID-19 vaccine than Canada, despite commitments last week that countries would share equally in a temporary drop in doses.

On Friday, the federal government announced vaccine deliveries to Canada would be cut by half for a four-week period starting Jan. 25. The pharmaceutical giant said the slowdown was needed to allow the company to retool its Belgian plant in order to expand production.

Major-General Dany Fortin, who is leading Canada’s vaccine logistics, said the loss would be made up in the subsequent weeks, with the company still delivering all four million vaccine doses in the first quarter — as previously committed.

Story continues below advertisement

When will Canada’s general vaccination for COVID-19 begin? The federal and provincial rollout plans so far

Can COVID-19 vaccines be combined? Do they work against variants? Pressing pandemic questions answered

How many coronavirus cases are there in Canada, by province, and worldwide? The latest maps and charts

Maj-Gen. Fortin also said that every country that has purchased Pfizer vaccines will be “affected equally.” But after first laying out a three- to four-week slowdown in shipments to European countries, the company later said shipments would resume their original schedule to European Union members the week of Jan. 25.

The vaccine is delayed in Canada as COVID-19 infections continue to rise and as pressure on hospitals remains high in many parts of the country. Ontario reported 3,422 new infections on Sunday, along with 69 deaths. The numbers were based on nearly 60,200 tests.

Procurement Minister Anita Anand said in an e-mailed statement Sunday that Ottawa has reiterated to Pfizer the importance of Canada returning to its regular delivery schedule of vaccines, but no explanation was provided for the discrepancy.

“I understand and share the concerns of Canadians regarding the temporary delivery delay of Pfizer doses,” Ms. Anand said. “We are once again in touch with representatives from Pfizer to reiterate firmly the importance for Canada to return to our regular delivery schedule as soon as possible.”

Canada was previously expecting to receive 208,650 doses in the last week of January and about 367,000 doses each week in February. Instead, about 655,000 of those doses will be delivered later.

Based on publicly released delivery numbers, the drop will translate to approximately 327,000 people getting their two-shot vaccine later than expected.

The slowdown means Ontario will increase the interval between the two shots needed to maximize the protection provided by the vaccine, from the company-recommended 21 days to up to 42 days. On Friday, British Columbia said it was also evaluating whether it would need to increase the interval between the shots.

Story continues below advertisement

Ms. Anand said Pfizer assured the government it is deploying all efforts to return Canada to its original delivery schedule as soon as possible. “This is an evolving situation. As soon as updated information on the delivery of Pfizer doses for Canada is available, we will share it with Canadians,” she said.

Europe had initially been advised it would face a similar delay as Canada. Germany’s Health Ministry had said Friday that Pfizer informed the European Commission it would not be able to fulfill all of its promised deliveries in the next three to four weeks. European Commission President Ursula von der Leyen said she “immediately called the CEO of Pfizer.”

On Friday, Prime Minister Justin Trudeau said at his press conference that the setback was “out of our hands” and that’s why Canada has contracts with several vaccine developers.

Christina Antoniou, a spokesperson for Pfizer, said in an e-mailed statement Sunday that because of the improvements the company is undertaking to scale up capacity, vaccine shipments will be temporarily affected in late January and early February, but it will allow for a significant increase in late February and March.

“The principle of equity is used when considering allocation of doses worldwide and we expect to have more information in the coming days,” Ms. Antoniou said.

Conservative health critic Michelle Rempel Garner said in an e-mailed statement that it is up to the Prime Minister to explain to Canadians why they will not be able to get vaccinated for months after people in other countries, such as the United States.

Story continues below advertisement

“It’s up to him to explain why, based on Friday’s news about vaccine delivery delays, we might be looking at many more months of lockdown – with the lost jobs, time with families, and mental health challenges that accompany them – while vaccines are being delivered to countries like the United States. It’s also up to him to find better path forward; if his Plan A has failed, what’s Plan B?” asked Ms. Rempel Garner.

With a report from the Associated Press

Sign up for the Coronavirus Update newsletter to read the day’s essential coronavirus news, features and explainers written by Globe reporters.

Let’s block ads! (Why?)



Source link

Continue Reading

Business

Roots sees room for expansion in activewear, reports $5.2M Q2 loss and sales drop

Published

 on

 

TORONTO – Roots Corp. may have built its brand on all things comfy and cosy, but its CEO says activewear is now “really becoming a core part” of the brand.

The category, which at Roots spans leggings, tracksuits, sports bras and bike shorts, has seen such sustained double-digit growth that Meghan Roach plans to make it a key part of the business’ future.

“It’s an area … you will see us continue to expand upon,” she told analysts on a Friday call.

The Toronto-based retailer’s push into activewear has taken shape over many years and included several turns as the official designer and supplier of Team Canada’s Olympic uniform.

But consumers have had plenty of choice when it comes to workout gear and other apparel suited to their sporting needs. On top of the slew of athletic brands like Nike and Adidas, shoppers have also gravitated toward Lululemon Athletica Inc., Alo and Vuori, ramping up competition in the activewear category.

Roach feels Roots’ toehold in the category stems from the fit, feel and following its merchandise has cultivated.

“Our product really resonates with (shoppers) because you can wear it through multiple different use cases and occasions,” she said.

“We’ve been seeing customers come back again and again for some of these core products in our activewear collection.”

Her remarks came the same day as Roots revealed it lost $5.2 million in its latest quarter compared with a loss of $5.3 million in the same quarter last year.

The company said the second-quarter loss amounted to 13 cents per diluted share for the quarter ended Aug. 3, the same as a year earlier.

In presenting the results, Roach reminded analysts that the first half of the year is usually “seasonally small,” representing just 30 per cent of the company’s annual sales.

Sales for the second quarter totalled $47.7 million, down from $49.4 million in the same quarter last year.

The move lower came as direct-to-consumer sales amounted to $36.4 million, down from $37.1 million a year earlier, as comparable sales edged down 0.2 per cent.

The numbers reflect the fact that Roots continued to grapple with inventory challenges in the company’s Cooper fleece line that first cropped up in its previous quarter.

Roots recently began to use artificial intelligence to assist with daily inventory replenishments and said more tools helping with allocation will go live in the next quarter.

Beyond that time period, the company intends to keep exploring AI and renovate more of its stores.

It will also re-evaluate its design ranks.

Roots announced Friday that chief product officer Karuna Scheinfeld has stepped down.

Rather than fill the role, the company plans to hire senior level design talent with international experience in the outdoor and activewear sectors who will take on tasks previously done by the chief product officer.

This report by The Canadian Press was first published Sept. 13, 2024.

Companies in this story: (TSX:ROOT)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

Talks on today over HandyDART strike affecting vulnerable people in Metro Vancouver

Published

 on

 

VANCOUVER – Mediated talks between the union representing HandyDART workers in Metro Vancouver and its employer, Transdev, are set to resume today as a strike that has stopped most services drags into a second week.

No timeline has been set for the length of the negotiations, but Joe McCann, president of the Amalgamated Transit Union Local 1724, says they are willing to stay there as long as it takes, even if talks drag on all night.

About 600 employees of the door-to-door transit service for people unable to navigate the conventional transit system have been on strike since last Tuesday, pausing service for all but essential medical trips.

Hundreds of drivers rallied outside TransLink’s head office earlier this week, calling for the transportation provider to intervene in the dispute with Transdev, which was contracted to oversee HandyDART service.

Transdev said earlier this week that it will provide a reply to the union’s latest proposal on Thursday.

A statement from the company said it “strongly believes” that their employees deserve fair wages, and that a fair contract “must balance the needs of their employees, clients and taxpayers.”

This report by The Canadian Press was first published Sept. 12, 2024.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

Transat AT reports $39.9M Q3 loss compared with $57.3M profit a year earlier

Published

 on

 

MONTREAL – Travel company Transat AT Inc. reported a loss in its latest quarter compared with a profit a year earlier as its revenue edged lower.

The parent company of Air Transat says it lost $39.9 million or $1.03 per diluted share in its quarter ended July 31.

The result compared with a profit of $57.3 million or $1.49 per diluted share a year earlier.

Revenue in what was the company’s third quarter totalled $736.2 million, down from $746.3 million in the same quarter last year.

On an adjusted basis, Transat says it lost $1.10 per share in its latest quarter compared with an adjusted profit of $1.10 per share a year earlier.

Transat chief executive Annick Guérard says demand for leisure travel remains healthy, as evidenced by higher traffic, but consumers are increasingly price conscious given the current economic uncertainty.

This report by The Canadian Press was first published Sept. 12, 2024.

Companies in this story: (TSX:TRZ)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending

Exit mobile version